mylan-perindopril arginine tablet
mylan pharmaceuticals ulc - perindopril arginine - tablet - 5mg - perindopril arginine 5mg - angiotensin-converting enzyme inhibitors
mylan-perindopril arginine tablet
mylan pharmaceuticals ulc - perindopril arginine - tablet - 10mg - perindopril arginine 10mg - angiotensin-converting enzyme inhibitors
perindopril arginine/indapamide tad 5 mg/1.25 mg tablets
tad pharma gmbh - perindopril arginine; indapamide - tablet - perindopril and diuretics
perindopril arginine/indapamide tad 10 mg/2.5 mg tablets
tad pharma gmbh - perindopril arginine; indapamide - tablet - perindopril and diuretics
perindopril arginine/amlodipine tad 10 mg/10 mg tablets
tad pharma gmbh - perindopril arginine; amlodipine - tablet - perindopril and amlodipine
perindopril arginine/amlodipine tad 10 mg/5 mg tablets
tad pharma gmbh - perindopril arginine; amlodipine - tablet - perindopril and amlodipine
perindopril arginine/amlodipine tad 5 mg/10 mg tablets
tad pharma gmbh - perindopril arginine; amlodipine - tablet - perindopril and amlodipine
perindopril arginine/amlodipine tad 5 mg/5 mg tablets
tad pharma gmbh - perindopril arginine; amlodipine - tablet - perindopril and amlodipine
coversyl 10 perindopril arginine 10 mg tablet bottle
servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: macrogol 6000; magnesium stearate; hydrophobic colloidal silica anhydrous; lactose monohydrate; sodium starch glycollate; maltodextrin; colour - coversyl is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that coversyl be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of coversyl has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
coversyl 5 perindopril arginine 5 mg tablet bottle
servier laboratories (aust) pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: maltodextrin; macrogol 6000; lactose monohydrate; hydrophobic colloidal silica anhydrous; magnesium stearate; sodium starch glycollate; colour - coversyl is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that coversyl be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of coversyl has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.